Podcasts about MHT

In this Healthed lecture, Professor Rod Baber uses a case study to demonstrate how best to assess a woman presenting with troublesome menopausal symptoms. He will then discuss the relevant, evidence-based recommendations for prescribing MHT, including appropriate mode of delivery, dosage, monitoring of effectiveness and side effects, as well as what to do when response is inadequate - it is not just a case of increasing the dose.See omnystudio.com/listener for privacy information.

Menopause is a natural phase of life, but for many women, it's filled with confusion, discomfort, and a frustrating lack of support. From hot flashes and joint pain to brain fog, mood swings, and disrupted sleep, the symptoms of menopause can be physically exhausting, emotionally taxing, and even socially isolating. What makes it harder? We're still not talking about it enough. For decades, menopause has been treated like a taboo subject. Women are often left to suffer in silence, unsure if what they're going through is “normal,” and hesitant to ask for help. But it doesn't have to be this way. There are proven strategies to help you manage symptoms, protect your long-term health, and feel like yourself again.  And some of the most effective solutions are surprisingly simple, starting with your lifestyle. Menopause doesn't have to be a downward spiral.  It can be a powerful opportunity to revamp your habits, strengthen your body, and take charge of your well-being for the next chapter of your life. Is hormone therapy safe, and who should consider it? What simple lifestyle shifts can dramatically ease your symptoms? In this episode, I'm joined by Dr. Malini Sharma, a board-certified OB/GYN and lifestyle medicine practitioner with a deep passion for helping women navigate menopause with confidence.  She breaks down the symptoms, treatment options, and small-but-mighty changes that can help you feel better, physically, mentally, and emotionally.   Things You'll Learn In This Episode  -The symptoms no one talks about Menopause has many well-known symptoms, but what are the lesser-known challenges women face?  -The emotional impact of menopause Menopause doesn't just change how you feel physically, it can take a toll on your mental health. What are some of the emotional and social challenges that come with it? -Addressing early menopause Premature ovarian insufficiency affects younger women, sometimes even in their 20s. How do you spot it early? How do you deal with it?  -MHT: safe or scary Hormone therapy has a controversial reputation, but the truth is more nuanced. Who is it right for? Have the risks been misunderstood?    Guest Bio Dr. Malini Sharma is a Consultant Gynaecologist, Lifestyle Medicine Practitioner and a staff physician at the Surgical Specialties Institute at Cleveland Clinic Abu Dhabi. Before joining Cleveland Clinic Abu Dhabi, Dr. Sharma worked at Mediclinic Hospital, Abu Dhabi, and Kings College Hospital Clinics, Abu Dhabi. Dr. Sharma received her medical degree from the University of London, England. She completed her postgraduate training in Northwest London deanery. Throughout her tenure, Dr. Sharma has specialized in obstetrics and gynecology, completing over 3000 gynecology operations. Connect with Dr. Sharma on LinkedIn.     About Your Host Hosted by Dr. Deepa Grandon, MD MBA, triple board-certified physician with over 23 years of experience working as a Physician Consultant for influential organizations worldwide. Dr. Grandon is the founder of Transformational Life Consulting (TLC) and an outspoken faith-based leader in evidenced-based lifestyle medicine.   ​​TLC is presenting this podcast as a form of information sharing only. It is not medical advice or intended to replace the judgment of a licensed physician. TLC is not responsible for any claims related to procedures, professionals, products, or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services, or methods that might be referenced.   Check out this episode on our website, Apple Podcasts, or Spotify, and don't forget to leave a review if you like what you heard. Your review feeds the algorithm so our show reaches more people. Thank you!   

This podcast series was sponsored by Theramex UK who had no input in the content which was developed by EMJ. The speakers were selected by Theramex and received honorarium. The views and opinions expressed in this podcast are those of the individual speakers and do not necessarily reflect those of Theramex or EMJ. Please refer to local marketing authorisation and prescribing practices for guidance. The Effect of HRT on Brain Function and Mental Health. - Episode 3 - Brain health expert Rossella Nappi joins Hannah Moir to discuss the effect of MHT on brain function and mental health. In this podcast series, we focus on women's health and the impact of menopause. Our experts explore the role and long-term impact of menopausal hormone therapy (MHT), otherwise referred to as hormone replacement therapy (HRT), on our heart, bones, and brain.

See all the Healthcasts at https://www.biobalancehealth.com/healthcast-blog Menopausal Symptoms I waited to announce the emerging research regarding the safety of post-menopausal hormone replacement therapy for breast cancer patients suffering from severe menopausal symptoms until the research finally supported my belief that women have the right to receive the treatment that they need if they accept the risks of that treatment. The past year of research (2024-2025) has produced a significant amount of research demonstrating the health risks associated from not taking hormone replacement therapy, as well as the safety of using testosterone after breast cancer and the limited risks of hormone replacement therapy following breast cancer. I have practiced women's medicine for over 40 years, and I believe that female patients should have the right to receive post-menopausal hormone therapy if they understand and accept the associated risks and benefits, as long as it is administered safely. Let me pause here to discuss how doctors ethically make decisions about treatment. First, the aim of medical treatment is to improve health and longevity while alleviating symptoms. It is a doctor's responsibility to evaluate, treat, and advise patients on the best course of therapy based on their medical training, practical experience, and the latest research. However, the third factor is often overlooked when advising patients about hormone replacement therapy after breast cancer. Doctors determine the best course of treatment by using this information and weighing the benefits of a treatment against its risks. We are trained to provide this information to patients to facilitate informed decision-making with the patient, not for the patient. This process requires time that doctors no longer have. Ah, and therein lies the problem. Doctors are trained to follow research related to the diseases and conditions they treat and to integrate that research into their practice. The basic decision-making process involves weighing the benefits of treatment (or no treatment) against the associated risks. When the benefits of a treatment outweigh its risks, it is recommended to the patient. “Recommended” means the doctor, based on current knowledge, believes it to be safer and more effective for the patient's health to pursue a specific treatment. However, this does not imply that the patient must follow the doctor's advice. A patient is autonomous and can assess the risks and benefits once informed, allowing them to refuse a treatment or request one that falls outside current medical guidelines. Doctors do not have to embark on a treatment they do not believe is beneficial or safe. Doctors have autonomy as well! Doctors in mainstream medicine adhere to “medical guidelines” established by our specialties, which represent the minimum level of care expected from a physician. However, these guidelines are often decades behind current research, meaning that the risks and benefits communicated to a patient may be outdated. A legal requirement known as informed consent mandates that a doctor inform the patient or include this information in a consent form that the patient reads and signs, detailing the procedure or treatment. If the treatment is newer than the guidelines, it is categorized as “off-label.” It is essential for the doctor to inform the patient that the treatment does not conform to current guidelines, and the patient must acknowledge the known risks associated with the treatment. At BioBalance Health®, we often find ourselves ahead of the guidelines, and my experience indicates it may take up to 20 years for the guidelines to catch up with us. Much of our treatment is considered off-label because it is current and ahead of the guidelines. It is superior to other treatments and remains safe, but risks are inherent in every treatment! Now, let's return to breast cancer and the roles of estradiol, testosterone, and progesterone replacement. Here are the facts about breast cancer: Most breast cancer patients are post-menopausal, and have symptoms of menopause Not all types of breast cancer are stimulated by estradiol or progesterone, and therefore for these cancers hormone replacement therapy is safe. Breast Cancer patients with negative nodes who have had a bilateral mastectomy are candidates for hormone replacement therapy after their treatment. The risks of estrogen replacement for ER+ breast cancer patients may promote the growth of cancer cells, while testosterone replacement lowers the risk of recurrence and alleviates certain menopausal symptoms. When testosterone is combined with estradiol, the risk of developing breast cancer in all women is reduced. Testosterone enhances the quantity and activity of cancer-fighting T-killer and T-helper white blood cells. All breast cancer patients can manage menopause symptoms using testosterone pellet therapy and vaginal estrogen without an increased risk of recurrence. Do you remember when I mentioned that the risks of treatment should be balanced with the benefits of that same treatment? Recently, numerous research articles have outlined the benefits of estradiol treatment, which I included in my 2017 book, “The Secret Female Hormone: How Testosterone Replacement Can Change Your Life.” In early 2025, the safety of taking estradiol for menopausal women confirmed the less publicized research that had come before. The Journal of Endocrinology and Metabolism reported that women who underwent estradiol replacement after the age of 60 live 20% longer than those who do not take hormone replacement therapy. This challenges the guideline that advises OB-GYNs to discontinue hormone replacement therapy before the age of 60. The Benefits of Estrogen replacement after menopause, based on multiple research studies over the last 20 years is as follows: ERT alleviates symptoms such as dry vagina, painful intercourse, insomnia, hot flashes, and night sweats. Estrogen replacement prevents and treats osteoporosis in women. Testosterone replacement in women with osteoporosis can reverse the process of bone loss, bringing bone back to normal strength and decreasing fracture risk. Non-oral Testosterone and Estradiol can prevent arteriosclerotic heart disease. ERT and HRT decreases the risk of diabetes with aging. Estradiol replacement during the first decade after menopause can delay the onset of Alzheimer's disease and dementia by ten years. If you are genetically predisposed to developing Alzheimer's or dementia by age 80, E2 replacement may postpone this onset until you turn 90. Testosterone replacement in the first 10 years after menopause postpones the onset of Alzheimer's disease and dementia for an additional ten years. Testosterone boosts immune function in both sexes and diminishes the onset and severity of infectious diseases. Aging causes cognitive decline, marked by challenges in memory and thinking, and menopause speeds up this process. Testosterone and estradiol replacement therapies may aid in reversing this decline. Muscle mass decreases after menopause due to a decline in testosterone but replacing testosterone with bio-identical pellets restores muscle mass to premenopausal levels.   The latest medical article that inspired me to create this podcast was published in the journal Menopause, which discussed the challenges many women face after breast cancer treatment without hormone replacement for their severe menopausal symptoms. Here are the quotes I think you should hear: (MHT = Menopause Hormone Therapy) “Among 226 breast cancer survivors.. the menopause symptom burden was high and women's experience of menopause-related breast cancer after-care was poor. Few women felt actively involved in menopause treatment decisions.  The NICE breast cancer guideline (NG101) states that women with a history of breast cancer can be offered MHT in “exceptional” circumstances if other treatments have failed (off-label use). However, NICE does not define what “exceptional” circumstances are or who gets to decide. Up to 50% of breast cancer survivors, especially those with debilitating menopausal symptoms, may choose to accept a small increase in risk in exchange for an improved quality of life and/or to mitigate future health risks associated with chronic estrogen deficiency.  “Allowing”. women to have MHT only in “exceptional” circumstance undermines patient autonomy and limits a clinician's ability to integrate clinical knowledge and judgment with the best currently available evidence (which is decades behind clinical guidelines). Clinicians have a legal and ethical responsibility to patients to make informed treatment choices. If you have had breast cancer and are experiencing symptoms you no longer want to endure, my advice is to find a doctor with whom you can make an informed decision based on the latest research. It's important to understand and accept the risks and to sign a High-Risk Consent for HRT.  If you aren't that brave, then seek a physician who will prescribe testosterone pellets along with vaginal estradiol to alleviate some of your post-menopausal symptoms. Life is too short to follow guidelines that are 20 years out of date when you are suffering.

In this episode, Andrea Donsky, nutritionist, published menopause researcher and menopause educator, and co-founder of WeAreMorphus.com, interviews Dr. Anna Cabeca, MD, known as “The Girlfriend Doctor,” DO, OBGYN, FACOG,  and triple-board-certified physician specializing in gynecology, integrative medicine, and anti-aging and regenerative medicine. She is known for her expertise in women's health, hormone balance, and sexual health.This must-listen episode addresses the controversies around menopause hormone therapy and what you need to know about the safety and effectiveness of various treatments.Topics Covered:The key differences between birth control pills and bioidentical hormones Understanding menopause hormone therapy (MHT) and how to personalize it for your unique needsPractical tips for starting hormone therapy and why patches or creams might work better than pillsThe truth about the Women's Health Initiative study and why its findings don't apply to all types of hormone therapySimple ways to support your body's natural hormone detoxification processesDr. Cabeca's holistic approach to hormone health - looking beyond quick fixes to find real solutionsWhy testing mattersThe surprising connection between cholesterol and brain health through hormone productionHow your thyroid, vitamin D levels, and gut health affect your hormonesTips for maintaining intimate health, including safe use of DHEA cream (Julva)A fresh perspective on PCOS and what it means for youWhich ingredients to avoid in hormone creams and whyLinks from the show:Dr. Anna Cabeca's Website: https://drannacabeca.com/Dr. Anna Cabeca's Books: https://amzn.to/4hVfdxrJulva Cream https://bit.ly/43u9rz9Send us a text ✅ Fill out our surveys Support our SPONSORS: Qualia https://bit.ly/42mtvmx CODE MORPHUS15 BEAM Minerals https://bit.ly/43MrfFL Code MORPHUS EnergyBits https://bit.ly/49f05YV Code MORPHUS Livon: https://bit.ly/3EjrcGG CODE MORPHUS Order 1 carton of Lypo-Spheric® Vitamin C at LivOnLabs.com & get 1 carton of B Complex Plus FREE ($56 value) just by adding both products to the cart Timeline: timeline.com/morphus CODE MORPHUS MyVitalC https://bit.ly/3EQ9bAf CODE MORPHUS15

In this Healthed lecture, Professor Rod Baber uses a series of case studies to discuss some of the challenges that clinicians face when managing women with menopausal symptoms. He will outline the appropriate assessment and management of symptomatic women with a history of conditions such as DVT, migraine, or cardiovascular disease, and explain how they can still access the benefits of MHT while minimising risks.See omnystudio.com/listener for privacy information.

The questions answered in this podcast are listed below.They were compiled by GPs and health professionals around Australia. Is fezolinetant (Veoza) safe for use in older populations, particularly those over 70? Is fezolinetant (Veoza) listed on the PBS? If not, what is its cost? Can fezolinetant (Veoza) be taken alongside other medications, such as thyroxine? How long is it safe for a woman to continue using fezolinetant (Veoza)? Is fezolinetant (Veoza) suitable for use during the perimenopausal stage? Can fezolinetant (Veoza) be used in combination with an estrogen patch or gel for women who still experience vasomotor symptoms? Is fezolinetant (Veoza) safe to use alongside other medications, such as Oxybutynin or SSRIs? Do we have any data on interactions? Is fezolinetant (Veoza) safe for young women with aggressive breast cancer who are undergoing hormone therapy? How should a woman transition from menopausal hormone therapy (MHT) to fezolinetant (Veoza)? Can low-dose MHT be used alongside fezolinetant (Veoza)? For women who have undergone chemotherapy for breast cancer and have abnormal liver function tests post-treatment, should fezolinetant (Veoza) only be started once liver function returns to normal? Should fezolinetant (Veoza) be discontinued if liver function tests become abnormal during treatment? Is there any evidence that fezolinetant (Veoza) helps with memory and concentration issues in menopausal women? Why does fezolinetant (Veoza) cause endometrial hyperplasia? Could you confirm whether the endometrial hyperplasia observed in clinical trials was benign? Is fezolinetant (Veoza) suitable for women with a personal or family history of breast cancer? Is there any data on the effects of fezolinetant (Veoza) beyond 52 weeks? Were women from diverse ethnic backgrounds, beyond America and Europe, included in the trials? What are the recommendations regarding the effect of fezolinetant (Veoza) on liver function? How should liver function be monitored, and when should testing be repeated or the medication stopped? Can GPs prescribe fezolinetant (Veoza), or is it restricted to specialists? Is fezolinetant (Veoza) appropriate for men experiencing hot flushes due to hormone blockers for prostate cancer (off-label use)? Patient Case: I have a patient currently on fezolinetant (VEOZA®), Pristiq, and Tamoxifen. What would you recommend in this case? Patient Case: I have a mid-40s patient suffering from frequent hot flushes every 10-15 minutes, despite being on the maximum dose of MHT. Can fezolinetant (VEOZA®) be used in combination with MHT to target these hot flushes? Also, what are your thoughts on testosterone? Some of my patients use compounded testosterone to manage their symptoms. Would this be helpful for this patient, and can testosterone be used alongside fezolinetant (VEOZA®)? Patient Case: A patient started fezolinetant (VEOZA®) nearly a month ago to address almost hourly sweats and flushes. Initially, she saw a significant improvement for the first 5 days, but now the frequency and severity of symptoms have gradually returned. Is this tachyphylaxis, or should the dosage of fezolinetant (VEOZA®) be increased? Should it be used intermittently? How should I advise this patient? Host: Dr Terri Foran | Total Time: 29 mins Expert: Dr Rod Baber, Obstetrician and Gynaecologist Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEDT Click here to register for the next oneSee omnystudio.com/listener for privacy information.

In this episode, we dive into the complex relationship between ADHD and menopause, exploring how hormonal shifts can intensify ADHD symptoms. Many women with ADHD find that perimenopause brings heightened struggles with focus, executive functioning, and emotional regulation. As estrogen declines, so does dopamine—an essential neurotransmitter for motivation and attention—worsening ADHD-related brain fog, forgetfulness, and mental fatigue. These changes can feel overwhelming, but understanding the biological connections between ADHD and menopause is key to managing them effectively.Despite the challenges, ADHD isn't just a collection of deficits; it also comes with unique strengths such as creativity, resilience, and dynamic problem-solving. However, during perimenopause, declining estrogen can make it harder to harness these gifts. Women may feel more scattered, struggle with organization, or experience mood swings that disrupt daily life. Fortunately, effective treatments can help restore balance. Stimulant medications remain a cornerstone of ADHD management, but cognitive behavioral therapy (CBT) and mindfulness practices can also be powerful tools for improving focus and emotional regulation. These strategies build structure, enhance self-awareness, improve overall well-being, and help women work on lifestyle interventions, such as sleep, nutrition, and exercise. Additionally, menopause hormone therapy (MHT) can be a game-changer for some women. By stabilizing estrogen levels, MHT may help mitigate the cognitive effects of menopause and support dopamine function, making ADHD symptoms more manageable. When used alongside stimulants, hormone therapy can offer a more comprehensive approach to treatment, addressing both the hormonal and neurological aspects of ADHD. Whether through medication, lifestyle changes, or a combination of treatments, midlife women with ADHD can regain control, optimize their cognitive function, and continue to thrive.Dr. Adrienne Mandelberger, MD is a board-certified gynecologic surgeon and menopause specialist. She is the founder of Balanced Medical, a gynecology and preventative women's health practice on Long Island, NY, and the founder and CEO of the virtual education company All Things Menopause™. Dr. Mandelberger is passionate about educating and empowering women to make informed choices during the menopause transition. Her special interests include the intersection of ADHD and perimenopause.Medical Disclaimer:By listening to this podcast, you agree not to use this podcast as medical advice or to make any lifestyle changes to treat any medical condition in yourself or others. Consult your own physician for any medical issues that you may be having. This entire disclaimer also applies to any of my guests on my podcast.Find Dr. Mandelberger here:Website: https://www.balancedmedicalny.com/IG: @DrMandelberger Educational Program: https://www.all-things-menopause.com/Stay in touch with JFW:Watch on my YouTube channel: https://www.youtube.com/@jillfooswellness/videosFollow me on Instagram: https://www.instagram.com/jillfooswellness/Follow me on Facebook: https://www.facebook.com/jillfooswellnessGrab discounts on my favorite biohacking products: https://www.jillfooswellness.com/health-productsEnjoy 20% savings and free shipping at Fullscript for your favorite supplements by leading brands:https://us.fullscript.com/welcome/jillfooswellnessSubscribe to the JFW newsletter at www.jillfooswellness.com and receive your FREE Guide on How To Increase Your Protein in 5 Easy Steps and your free Protein Powder Recipe Ebook. Schedule your complimentary 30-minute Zoom consultation here:https://calendly.com/jillfooswellness/30-minute-zoom-consultations

In this episode of Moving Into the Future, host Jack Macejka, Vice President of National Accounts at The Advance Group, welcomes Greg Silverman, Vice President of Sales at MHT Technologies. Together, they explore how Power over Ethernet (PoE) has evolved from powering lighting systems to orchestrating fully connected, sensor-driven office environments. Greg breaks down how MHT’s hardware and software platforms reduce complexity, cut energy waste, and unlock real-time data from every corner of a workspace—from desk sensors to window shades. Tune in to hear how forward-thinking companies are reimagining their offices as dynamic ecosystems—and why the smartest infrastructure is the kind you can’t see. Catch more episodes at https://theadvancegrp.com/happenings/podcastSee omnystudio.com/listener for privacy information.

This podcast series was sponsored by Theramex UK who had no input in the content which was developed by EMJ. The speakers were selected by Theramex and received honorarium. The views and opinions expressed in this podcast are those of the individual speakers and do not necessarily reflect those of Theramex or EMJ. Please refer to local marketing authorisation and prescribing practices for guidance. Long-term Benefits of Use of MHT/HRT on the Heart, Bones, and Brain - Episode 1 - Heart expert Yassir Javaid joins Hannah Moir to discuss the role of MHT in cardiovascular health. In this podcast series, we focus on women's health and the impact of menopause. Our experts explore the role and long-term impact of menopausal hormone therapy (MHT), otherwise referred to as hormone replacement therapy (HRT), on our heart, bones, and brain.

This podcast series was sponsored by Theramex UK who had no input in the content which was developed by EMJ. The speakers were selected by Theramex and received honorarium. The views and opinions expressed in this podcast are those of the individual speakers and do not necessarily reflect those of Theramex or EMJ. Please refer to local marketing authorisation and prescribing practices for guidance. Long-term Benefits of Use of MHT/HRT on the Heart, Bones, and Brain - Episode 2 - Bone expert Kassim Javaid joins Hannah Moir to explore the impact of MHT on our bones. In this podcast series, we focus on women's health and the impact of menopause. Our experts explore the role and long-term impact of menopausal hormone therapy (MHT), otherwise referred to as hormone replacement therapy (HRT), on our heart, bones, and brain.

Menopause is a huge transition in a woman's life, yet it's often misunderstood and not talked about enough. In this episode, I'm sharing my personal journey approaching 50 and how I'm preparing for menopause, plus the key insights I gained from attending the So Hot Right Now Menopause Conference in Sydney. We'll unpack the myths around hormone therapy, why so many women struggle with weight gain and insulin resistance, and how nutrition, strength training, and stress management can help women thrive—not just survive—during menopause. What I Covered in This Episode 1️⃣ The Reality of Menopause Why menopause isn't just about hot flushes—it affects mood, sleep, brain function, and more. How hormonal changes impact insulin resistance, weight gain, and energy levels. The common misconceptions about menopause that leave many women suffering in silence. 2️⃣ The Truth About Hormone Therapy (MHT) Debunking the myths: Is HRT really safe? Understanding estrogen, progesterone, and testosterone therapy. The real benefits of MHT beyond symptom relief—think brain health, heart health, and bone strength. What I've learned as a GP—and why I'm now prescribing MHT more to help women feel their best. 3️⃣ Why Lifestyle Matters in Menopause Nutrition: Why increasing protein and reducing processed carbs & sugar is critical. Strength Training: Why walking alone isn't enough—women need to lift heavy to maintain muscle & bone health. Stress Management: The role of breathwork, mindfulness, and nervous system regulation in managing symptoms. Circadian Health: How morning sunlight & reducing blue light at night can improve sleep & hormone balance. 4️⃣ My Personal Approach to Menopause How I'm proactively preparing for menopause and balancing lifestyle, nutrition, and stress management. Why I'm continuing to learn, unlearn, and relearn about menopause to provide better care for my patients. The key mindset shifts every woman needs to embrace this transition with confidence & vitality. Key Takeaways

Could a $573.3 million investment revolutionise menopause health in Australia? Tune in to discover how this historic commitment from the Albanese government is set to transform menopause and perimenopause care across the nation. With bipartisan support ensuring the longevity of these initiatives, we explore the Senate Inquiries and Budget Submissions that paved the way for these groundbreaking developments and the profound impact they promise for countless women. This episode sheds light on how accessibility to menopause care is being reimagined, with Medicare rebates incentivising GPs to gain new skills and the expansion of existing clinics to include menopause specialists.With advocacy playing a crucial role in these advancements, hear about the collaborative efforts behind the scenes that have resulted in cost reductions for MHT like Prometrium and Estrogel. We wrap up with exciting news of an upcoming Dear Menopause interview with Assistant Minister Ged Kearney, promising an in-depth look into the policy changes that are shaking up women's healthcare. Don't miss your chance to submit questions for this insightful conversation, as we aim to bring you all the behind-the-scenes details and celebrate these significant strides in women's health.Links:Health Package Fact SheetEndometriosis and Pelvic Pain ClinicsThank you for listening to my show! Join the conversation on Instagram

In this episode of the Prescribing Lifestyle podcast, I'm joined by Tanya Rutherford, founder of Queen Be, a midlife transformational coach, and the host of the Navigating the Change Online Menopause Summit. We dive into the realities of midlife, perimenopause, and menopause, exploring how women can take control of their health and well-being during this stage of life. What We Covered in This Episode Meet Tanya Rutherford & Queen Be Tanya's journey into coaching and supporting women through midlife and menopause. The importance of education and awareness around hormonal changes. The Reality of Midlife & Menopause Common symptoms of perimenopause and menopause—beyond hot flashes! How midlife transitions impact mental health, relationships, and career. The role of menopause hormone therapy (MHT) and why it's gaining attention again. Navigating the Change Online Menopause Summit (Feb 3-6, 2025) A free online summit featuring expert discussions on menopause, lifestyle, relationships, and more. Followed by live workshops from Feb 10-21 for deeper insights and practical strategies. Access to additional resources, coaching, and a supportive community. How to Take Charge of Your Midlife Health Lifestyle strategies: nutrition, strength training, stress management, and sleep. Why understanding your body's changes is key to thriving in midlife. The power of community and support in navigating this stage of life. Key Takeaways Perimenopause and menopause are natural transitions that affect every woman differently. Many symptoms (like anxiety, brain fog, and fatigue) are often overlooked as hormonal changes. Women need to advocate for their health, seek education, and explore different treatment options. Community and expert guidance can make the midlife journey empowering rather than overwhelming. Resources Mentioned Queen Be Website & Summit Details

On June 15, 2015, the Modi government launched the Smart Cities Mission, aiming to transform India's urban landscape with a focus on public safety, water supply, waste management, health, education, and mobility. Despite these efforts, 49% of India's urban population still lived in slums in 2020, according to World Bank data. The Mahila Housing Trust (MHT) has been bridging this gap since 1994. Working closely with local governments, MHT empowers women in low-income communities to improve their living conditions, access essential services, and build climate resilience. Till date, MHT has transformed lives of over 50 lakh individuals across South Asia. In this episode, Ms. Bharti Bhonsale, Programme Manager at MHT, discusses their work in transforming cities, shaping participatory urban planning, and redefining sustainable living. Tune in.

The conversation around hormone therapy for menopausal symptoms is pretty clear. Hormone therapy is the gold standard for treating hot flashes and night sweats and can help with many other common symptoms that come with the menopause transition. It's very effective and broadly safe. But recently, the conversation has evolved past symptom management and into preventative health with many experts suggesting that hormone therapy may play a larger role in extending a woman's healthspan, if not lifespan. That maybe we should all start taking hormones to protect our hearts and cognitive health. And there's promising research in those areas. Yet none of the medical associations recommend hormones for those purposes. Why? That's what we dig into this week with Professor Susan Davis, AO, who is a pioneer and leading expert in women's health as a clinical endocrinologist, researcher, and educator. She reflects on her decades of research on various forms of hormone therapy and shares what we know–and still don't know–today regarding traditional hormone therapy as well as testosterone therapy for women's health post menopause.Professor Susan R Davis AO, MBBS, FRACP, PhD, FAHMS is a clinician researcher with expertise in the role of sex hormones in women across the lifespan. She is Head of the Monash University Women's Health Research Program and holds a Level 3 NHMRC Investigator Grant. Susan is a Consultant Endocrinologist and Head of the Women's Endocrine Clinic, Alfred Hospital Melbourne and a consultant at Cabrini Medical Centre. She is a Fellow and Council Member of the Australian Academy of Health and Medical Sciences. She is a past President of the Australasian Menopause Society and the International Menopause Society. She has over 435 peer-reviewed publications and has received numerous national and international prestigious research awards. Susan was appointed an Officer of the Order of Australia for distinguished service to medicine, to women's health as a clinical endocrinologist and researcher, and to medical education. You can learn more about her and her work at Monash University.Resources2023 Practitioner's Toolkit for Managing Menopause hereMenopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery hereUse of MHT in women with cardiovascular disease: a systematic review and meta-analysis hereStudying Studies: Part I – relative risk vs. absolute risk by Peter Attia, MD, hereJoin the Feisty Girona Gravel Camp: https://www.thomsonbiketours.com/trips/feisty-girona-gravel-camp/ Subscribe to the Feisty 40+ newsletter: https://feistymedia.ac-page.com/feisty-40-sign-up-page Follow Us on Instagram:Feisty Menopause: @feistymenopause Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099 Support our Partners:Lagoon Sleep: Go to LagoonSleep.com/hitplay and use the code HITPLAY to get $25 off any pillow between now and December 2, 2024. Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/ Nutrisense: Go to nutrisense.io/hitplay and book a call with a Registered Dietitian Previnex: Get 15% off your first order with code HITPLAY at...

This has been a big year for menopause education and I'm excited about it! With the realization that most medical doctors do not receive any training there is a call for more awareness and education. Talking about hormones (menopause hormone therapy MHT) and menopause in general should become less daunting as more MD's become trained in this area of medicine. Other evidence based takeaways from 2024 that are talked about:Best foods to support the menopause transitionBest ways to manage specific symptoms Best insights on weight and metabolismThe best self care habits that stuckThe best lessons I learned this yearLinks mentioned in the episode:The More Joy Less Stress Healthy Holiday Reset, click HERE to join (it's free!)The Menopause Society click HEREI want to hear from you! heather@heathercarey.comI would love to hear from you! What did you think of the episode? Share it with me :) Let's Be FriendsHang out with Heather on IG @greenpalettekitchen or on FB HERE.Let's Talk!Whether you are looking for 1-1 nutrition coaching or kitchen coaching let's have a chat. Click HERE to reach out to Heather.Did You Love This Episode? "I love Heather and the Real Food Stories Podcast!" If this is you, please do not hesitate to leave a five-star review on Apple or wherever you listen to podcasts.

Join Johanna Wicks and me in today's Hot Take as we unravel the complicated process of getting treatments added to Australia's PBS, sparked by a recent breakthrough announcement about endometriosis medication. We explore the pivotal, yet often misunderstood, roles that pharmaceutical companies and the government play in this process and why modern menopause hormone therapy (MHT) hasn't yet made it to the PBS despite public demand.Delving deeper, we contrast MPA, a synthetic progestin, with body-identical progesterone and critique the Pharmaceutical Benefits Advisory Committee's (PBAC) tendency to group these therapies together. This sheds light on the broader issue of insufficient research funding in women's health.As we look forward, our anticipation builds around the government's response to the Senate Inquiry report and its potential impacts on women's health policy, especially with an upcoming election. Will Australian women receive an early Christmas gift from the Government? We hope so!Jo shares about attending Em Rusciano's impactful "Outgrown" show. And to wrap the year up, have you checked out our creative "Menopause Myths Advent Calendar 2024" on Instagram — a fun, festive initiative aimed at busting menopause myths with a sprinkle of Christmas joy. Thank you for your continued support and here's to more insightful discussions in the new year!Links:Pharmaceutical Benefits Advisory Committee (PBAC)Em RuscianoThe Holderness Family - Instagram Christmas Reel2024 Advent Calendar - InstagramThank you for listening to my show! Join the conversation on Instagram

Amanda Thebe, author of the bestselling book Menopocalypse: How I Learned to Thrive During Menopause and How You Can Too. Amanda's journey from a personal trainer to a leading advocate for women's health in menopause.Amanda's Menopause Journey: Amanda shares her struggles with perimenopause, including misdiagnoses and lack of support, which inspired her to dive into evidence-based research and create a platform for helping women navigate menopause with confidence.Misinformation and Advocacy: They discuss the predatory marketing practices targeting menopausal women, emphasizing the importance of seeking valid, evidence-based information and avoiding "magic pill" solutions.The Role of Hormone Therapy: Amanda breaks down menopause hormone therapy (MHT), debunking myths, clarifying its role, and stressing the need for individual discussions with healthcare providers. Lifestyle Overhaul: Both women highlight the power of lifestyle choices—nutrition, strength training, and sleep—on reducing symptoms and improving quality of life during menopause.Consistency is Key: Amanda introduces her "auto-regulation" approach to exercise, encouraging women to adjust workouts based on daily energy levels, fostering consistency over intensity.A Positive Narrative: They conclude with a focus on reframing menopause as a natural transition rather than a period of doom and gloom, urging listeners to lean into the change and thrive.Resources and Recommendations:Amanda's website: amandathebe.comFollow Amanda on Instagram: @amandathebeMenopause resources: Menopause Society https://menopause.org/Gennev telemedicine services https://www.gennev.com/Book recommendations: Menopocalypse by Amanda Thebe https://a.co/d/76JMIgCThe Hormone Doctor Annice Mukherjee https://www.instagram.com/the.hormone.doc/?hl=enAmanda and Kathy close the conversation by encouraging women to be informed, advocate for themselves, and continue the conversation around menopause. It's an empowering episode for anyone seeking clarity and support through this transformative phase.Thank you so much for listening, please share with a friend and subscribe so you don't miss an episode!If you want to see how we can help you on your journey, book a quick 10-15 minute call so we can chat about your goals!https://www.menopotmeltdown.com/quickchatnowFree Macro/Calorie Calculator https://plan.katalystfitness.net Coaching Process Video and booking link https://www.menopotmeltdown.com/mmmcoachingapp Now accepting clients, use the link to apply for 1:1 coaching:https://www.menopotmeltdown.com/mmmcoachingappFree No BS Menopause Secrets Facebook group: https://www.facebook.com/groups/kathykatalyst/?ref=shareFor all my social links: https://bit.ly/kathykatalystDo you have a question that you would like answered on the show? Please ask your question here:https://go.katalystfitness.net/podcast-question-entryHave a personal question? Email me at kathycote9142@comcast.net

The gaps in knowledge around female hormonal changes (aka perimenopause and menopause)

The gaps in knowledge around female hormonal changes (aka perimenopause and menopause)

In this episode, I dive into the important topic of menopausal hormone therapy (MHT) and its relationship with breast cancer risk. I share my personal journey as a 53-year-old woman experiencing the challenges of menopause, including the sudden onset of severe joint pain and hot flashes. Despite maintaining a healthy lifestyle, I faced significant changes that led me to explore hormone therapy options. Throughout the discussion, I highlight the wealth of research supporting the safety and benefits of MHT, addressing common misconceptions stemming from the Women's Health Initiative (WHI). Tune in to learn more about the nuances of MHT, the importance of informed decision-making, and my empowering choice to embrace this therapy amidst my family's health history. To work with me: https://www.drmarbas.com/ A Big Thank You To Our Sponsors: If you want to work with the best Whole Foods plant-based body recomposition coach, I highly recommend checking out what www.fitvegancoaching.com offers. I did their program and was able to lose 7% of body fat, build lean muscle, and improve my running time. As a loyal subscriber, you get $250 savings on their coaching services. To learn plant-based cooking and get your medical questions answered, join The Healing Kitchen, taught by Brittany Jaroudi and me! Click here to learn more: https://www.drmarbas.com/the-healing-kitchen

In today's episode Elly McLean and I discuss the evolving conversation around perimenopause, menopause and menopausal hormone therapy (MHT). We emphasise the need for a personalised approach considering factors like family history, lifestyle, and metabolic health. We cover the importance of early preparation, including diet, stress management, and quality sleep, to mitigate perimenopausal symptoms and long-term health risks. We also discuss the roles of testing to understand hormone levels, the significance of the first hormonal change, which is almost always low progesterone and not estrogen, the shift in awareness and the importance of addressing misconceptions, particularly regarding the benefits of bioidentical hormone therapy and so much more.   Head to https://www.stephlowe.com/podcasts/508 for show notes, episode transcripts and more.

HRT (or MHT) isn't natural territory for The Happy Menopause podcast, but as it's the theme for this year's World Menopause Day, I thought it would be remiss of me not to cover it.HRT has become a pretty contentious issue in recent years, with a lot of people being very entrenched in the strongly for or strongly against position. And amongst all that there are quite a lot of self-styled experts, who are anything but expert in the matter! I've been concerned to see the impact this has had on women in midlife, who've often become confused, fearful or distressed about the lack of clarity and some of the disturbing messages about the risks if you do take it or the risks if you don't take it. As with all things, there is nuance here, so for this episode I've reached out to the excellent Kathy Abernethy whose menopause credentials are beyond question. She's a trained nurse and BMS menopause specialist who's been working as a clinician in the menopause arena since the 90s. Kathy is a hugely respected figure and has helped thousands of women over the years with her evidence-based advice and clinical support. She came on the show in Season 2 to talk about solutions for vaginal dryness, and I was delighted to welcome her back to shine a light on HRT, provide clarity and bust some of the many myths that are out there. We explore 12 key questions and myths about HRT. We look whether you can be too old or too young; how your medical history affects things; whether you're just putting off the inevitable; what happens if you don't take it; and more. Tune in for the inside track and a balanced, evidence-based view of this complex subject from someone who's a genuine expert. If you're interested in the diet and lifestyle side of menopause management, check out my other World Menopause Day special on 10 Foods to Focus on for the Menopause. And if you want ongoing support every month, you really should consider joining The Happy Menopause Club for bonus episodes, articles, Q&As and videos at thehappymenopause.com.If you've enjoyed the podcast, make sure you subscribe so you don't miss the next episode and please give it a 5-star rating and a short review on Apple podcasts, or whichever platform you listen on, I'd be so grateful. And do tell your friends and family about it too. It really does make a huge difference to the visibility of the podcast, so that more women can find the show. After all, every woman deserves to have a happy menopause. Check out the full Show Notes for this episode on my website www.well-well-well.co.uk/podcast, where you'll find all the relevant links and references for each guest.For ad-free listening, bonus episodes, plus a whole load of exclusive advice around menopause, join The Happy Menopause Club for just £6 per month. Learn how to build your own menopause diet to manage your symptoms with my latest book The Happy Menopause: Smart Nutrition to Help You Flourish.

Send us a textMove Daily Talks: Do You Need Hormone Replacement Therapy? Dr. Shafeena Premji | EPS. 17In this episode, Dr. Shafeena Premji discusses the complexities of hormone replacement therapy (MHT) for menopausal women, emphasizing that HRT/MHT is not universally recommended for all menopause-related symptoms and highlighting the importance of Health Canada-approved treatments. She advises that lifestyle changes, such as exercise and diet modifications, can often effectively manage menopause symptoms and reduce health risks. The conversation also touches on the importance of understanding the differences between various hormone therapies and the potential impacts of alcohol and diet on menopausal health.00:00 The complexities surrounding hormone therapy05:40 Indications and guidelines for hormone therapy11:24 Lifestyle factors can dtermine use of HRT17:04 Understanding bioidentical versus traditional hormone therapy22:48 Estrogen and heart health during menopause34:09 The impact of alcohol and diet on women's health39:34 Social connections and healthFollow on Instagram: @drshafeenapremji The Move Daily Membership is a paid monthly subscription for women, which gives you access to a huge amount of resources to help support you in reaching your health goals. Whether you're looking to lose fat, gain lean muscle, focus on your nutrition, give time to wellness or simply wish to dial in your overall health, we can support you in achieving your objectives. Join today!Support the showThanks for moving daily with us in your fitness, wellness and nutrition! Be sure to follow us here:YouTube: https://www.youtube.com/@TracySteenMoveDailyInstagram: https://www.instagram.com/movedailyfitness/Facebook: https://www.facebook.com/tracy.steen1TikTok: https://www.tiktok.com/@tracysteenSubscribe to my podcast! https://www.buzzsprout.com/2375873/support

Dr. Bodyl Brand (Oxford University, UK) joins AJP Audio to discuss the effectiveness of menopausal hormone therapy in preventing psychosis relapse in women with schizophrenia and schizoaffective disorder.  Afterwards, AJP Editor-in-Chief Dr. Ned Kalin takes us through the rest of the October issue of the American Journal of Psychiatry, which focuses on other issues touching psychosis and schizophrenia spectrum disorders. 01:05     Brand interview 03:08     MHT and potential side effects in schizophrenia treatment 06:16     Estrogen and psychosis prophylaxis 07:44     MHT effectiveness 10:15     Clinical implications 11:27     Strengths and limitations 13:47     The need for further study 15:54     Further research 17:24     Kalin interview 17:47     Brand et al. 20:17     Partanen et al. 23:54     Moran et al. 26:48     Gallucci et al. 30:38     Arion et al. Transcript Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it. Subscribe to the podcast here. Listen to other podcasts produced by the American Psychiatric Association. Browse articles online. How authors may submit their work. Follow the journals of APA Publishing on Twitter. E-mail us at ajp@psych.org

September is Perimenopause Awareness Month! And we are diving into all things perimenopause and menopause.A Brief History of Menopause in the 20th Century:Early 20th Century: With advancements in endocrinology, menopause was recognized as a hormonal shift due to declining levels of estrogen. In the 1930s and 40s, estrogen replacement therapy began to be explored as a treatment for menopausal symptoms.1960s and 1970s: The development of hormone replacement therapy (now called Menopausal Hormone Therapy or MHT) marked a significant change in how menopause was managed. Physicians began prescribing estrogen (and later, progesterone) to treat symptoms like hot flashes and to prevent conditions like osteoporosis.Feminist Movements: The 1960s-70s women's health movements challenged the medicalization of menopause, encouraging more holistic and natural approaches. Feminists highlighted that menopause was not a disease but a natural phase of life.In this episode, Dr. Renée Sentilles joins me to discuss the History of Menopause. Dr. Renée Sentilles is Henry Eldridge Bourne Professor of History at Case Western Reserve University, where she has been teaching since 2000. She is the author of two books and various articles, and is currently working on a new book, “In Her Shoes: Getting to the Sole of 20 th Century American Women's History,” which uses historic shoes engage readers in women's history.Follow us on social media: Instagram: @drrpope TikTok: @vulvadoctor Twitter: @drrpope LinkedInWant more from Our Womanity?If you enjoyed this episode of Our Womanity, please subscribe, rate, and leave a review. Your feedback helps us continue to bring you engaging and empowering content.

Half of the world's population will go through menopause. Yet research shows that a large proportion of women do not feel informed and equipped for menopause. In this episode, we reveal the results of a brand new study that highlight the impact of diet on menopause symptoms. Davina McCall is a British household name and much-loved TV presenter on a mission to change this. Her 2022 book Menopausing provided a roadmap for women to be fearless in tackling this stage of life. She has her own very personal menopause story and today, she shares it with us. Together with ZOE's Chief Scientist Dr. Sarah Berry, we're having an honest and open conversation about perimenopause and menopause.

The sixth episode in the HRT after breast cancer series features Lisa Colclough and Helen Widner, two breast cancer patients who decided to go down two very different routes. Helen decided to start testosterone pellet therapy whilst being on aromatase inhibitors, whilst Lisa decided to restart her HRT soon after her breast cancer treatment. This mini-series explores hormone replacement therapy (HRT) after breast cancer, a controversial and emotive subject. The conversation focuses on the further understanding of risks and benefits of HRT (hormone replacement therapy) or also MHT (menopause hormone therapy), the emotional impact on patients, and the different views among medical professionals. The goal is to provide understanding for patients seeking HRT after breast cancer and insight for doctors on how to move forward without robust evidence. Dani Binnington, host of the Menopause And Cancer podcast, and founder of the not-for-profit organisation Menopause And Cancer has spoken to hundreds of women who feel like they are in a void and have nowhere to turn to in discussing this difficult topic. Welcome to our HRT after breast cancer series.In this episode we discuss:What was the hardest part about menopause for each of them?We explore why Helen and Lisa thought about using hormone replacement therapy after their breast cancer diagnosis.Lisa discusses not being heard as a patient and why she was made to take action without her doctor's support. Helen discusses the hurdles to accessing testosterone pellet therapy in the UK.Episode Highlights:00:00 Intro.05:13 Postmenopausal risk versus benefits of aromatase inhibitors.08:36 Difficulties with tamoxifen, switched to HRT.11:58 Brain fog impacted daily life, resembling dementia.28:47 Desire for informed discussion about medical decisions.35:45 Research led to considering testosterone implants with AI.Connect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancerJoin our Facebook group: www.facebook.com/groups/menopauseandcancerchathub

The fifth episode in the HRT after breast cancer series features Tamzin, who many years after her breast cancer treatment for a hormone receptor-positive cancer decided to take HRT. Tamzin Rasmussen, a psychologist and psychotherapist from Australia has been proactive in participating in her medical treatments. Tamzin explores her decision to pursue hormone replacement therapy (HRT) after breast cancer treatment and the challenges she faced in discussing it with healthcare professionals. She discusses the importance of collaborative consultations and the need for healthcare practitioners to make room for nuance and uncertainty in treatment decisions. This mini-series explores hormone replacement therapy (HRT) after breast cancer, a controversial and emotive subject. The conversation focuses on the further understanding of risks and benefits of HRT (hormone replacement therapy) or also MHT (menopause hormone therapy), the emotional impact on patients, and the different views among medical professionals. The goal is to provide understanding for patients seeking HRT after breast cancer and insight for doctors on how to move forward without robust evidence. Dani Binnington, host of the Menopause And Cancer podcast, and founder of the not-for-profit organisation Menopause And Cancer has spoken to hundreds of women who feel like they are in a void and have nowhere to turn to in discussing this difficult topic. Welcome to our HRT after breast cancer series.In this episode we discuss:Why the decision to start hormone replacement therapy after a breast cancer diagnosis is a complex and personal oneWhy it is important for patients to have an open and informed discussions with their medical team to make treatment decisions that align with their goals and valuesWhy healthcare practitioners should make room for nuance and uncertainty in treatment discussions and consider the individual needs and preferences of each patientTamzin explains the benefits she started to experience when starting HRT despite her cancer diagnosisEpisode Highlights:00:00 Intro.04:13 Chemotherapy triggered abrupt menopause, causing side effects.07:33 Chemotherapy was awful, but brought relief.14:31 Took break, switched medications, adjusted for effectiveness.22:24 Cancer treatment induced menopause.31:13 Women afraid of discussing HRT openly.34:49 Oncologist approves oestrogen treatment for bone density.37:23 Improved sleep, increased energy, and better stamina.40:14 Conversation about bone health and medication concerns.43:57 Consider decision slowly, discuss with informed practitioners.48:38 Realising joy and richness in life's changes.Connect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancer Join our Facebook group: www.facebook.com/groups/menopauseandcancerchathubThe walking challenge I mention is here for you: https://move-with-menopause-and-cancer.raiselysite.com/

The fourth episode in the HRT after breast cancer series features Dr. Louise Newson, who has faced criticism for her willingness to prescribe HRT to breast cancer patients. At the same time, she has been described as a lifesaver by many of the women she treats.Dr. Louise Newson is a GP who has transformed the landscape for menopausal women worldwide. She became a member of the Royal College of Physicians in 1998 and a Fellow of the Royal College of GPs in 2016. She is also a menopause specialist and a member of the UK Government's Menopause Taskforce.This mini-series explores hormone replacement therapy (HRT) after breast cancer, a controversial and emotive subject. The conversation focuses on the further understanding of risks and benefits of HRT (hormone replacement therapy) or also MHT (menopause hormone therapy), the emotional impact on patients, and the different views among medical professionals. The goal is to provide understanding for patients seeking HRT after breast cancer and insight for doctors on how to move forward without robust evidence. Dani Binnington, host of the Menopause And Cancer podcast, and founder of the not-for-profit organisation Menopause And Cancer has spoken to hundreds of women who feel like they are in a void and have nowhere to turn to in discussing this difficult topic. Welcome to our HRT after breast cancer series.In this episode we discuss:Dr. Newson's passion for empowering women to navigate the menopause How it felt when Dr. Newson prescribed HRT to a breast cancer patient for the first timeThe role of shared-decision making Holding uncertainty between the doctor and the patientEmpowering women to make informed decisions about their health is crucial in improving their quality of lifeEpisode Highlights:00:00 Intro.03:09 Challenges of hormone replacement therapy after cancer.06:38 Doctor offers hormonal treatment to patient post-surgery.12:00 Alternative options suggested for women's health without HRT.20:45 Adjuvant treatment side effects and drug holidays.23:40 Discussing oestrogen management for cancer survivors post-menopause.30:28 Lack of research on women's health risks.44:04 Advocate for women's health and research needs.47:03 Effective communication between patients and doctors crucial.Connect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancer Join our Facebook group: www.facebook.com/groups/menopauseandcancerchathubThe walking challenge I mention is here for you: https://move-with-menopause-and-cancer.raiselysite.com/

The third episode in the HRT after breast cancer series features Dr. Tina Peers who discusses her decision to take HRT after her own breast cancer diagnosis and the decision-making process involved when prescribing it to patients. Dr. Tina Peers is a women's health specialist who began her career as a general practitioner in the early 80s. She became a Consultant in Contraception and Reproductive Health, and has expert knowledge in treating patients with long Covid, Histamine Intolerance, Mast Cell Activation Syndrome and of course the menopause. She is a colleague of Dr. Nick Panay, whom she met while working at Chelsea and Westminster Hospital, seeing complex menopause cases.This mini-series explores hormone replacement therapy (HRT) after breast cancer, a controversial and emotive subject. The conversation focuses on the further understanding of risks and benefits of HRT (hormone replacement therapy) or also MHT (menopause hormone therapy), the emotional impact on patients, and the different views among medical professionals. The goal is to provide understanding for patients seeking HRT after breast cancer and insight for doctors on how to move forward without robust evidence. Dani Binnington, host of the Menopause And Cancer podcast, and founder of the not-for-profit organisation Menopause And Cancer has spoken to hundreds of women who feel like they are in a void and have nowhere to turn to in discussing this difficult topic. Welcome to our HRT after breast cancer series.In this episode we discuss:How general healthcare treats the issue and not the root cause of many conditions, leaving many patients to suffer without the answers they seek. Dr. Peers discusses how her deep knowledge of helping patients with a rare disease helped her understand the importance of thinking outside the box. Why Peers decided to take HRT despite her breast cancer diagnosis. What does shared decision-making look like in practice?How to counsel women who might want to consider HRT after breast cancer? Episode Highlights:00:00 Intro.04:46 Shifted focus to women's health, led services.08:01 Breast cancer treatment.18:08 Seeking help led to meeting superb gynaecologist.20:36 Seeking HRT without GP approval.25:27 Benefits of HRT: cardiovascular, bone, cognitive, longevity33:09 Specialist clinic supports post-breast cancer HRT patients.Connect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancer Join our Facebook group: www.facebook.com/groups/menopauseandcancerchathubThe walking challenge I mention is here for you: https://move-with-menopause-and-cancer.raiselysite.com/

The second episode in the HRT after breast cancer series features oncologist Prof. Richard Simcock who will discuss potential pathways for using HRT after breast cancer despite the lack of robust data.Prof Simcock is a consultant clinical oncologist at University Hospitals Sussex NHS Foundation Trust, where he provides clinical care to people with breast cancer. He is also the consultant medical adviser for our friends at the charity Macmillan Cancer Support and an Honorary Professor at Brighton and Sussex Medical Schools.This mini-series explores hormone replacement therapy (HRT) after breast cancer, a controversial and emotive subject. The conversation focuses on the further understanding of the risks and benefits of HRT (hormone replacement therapy) or also MHT (menopause hormone therapy), the emotional impact on patients, and the different views among medical professionals. The goal is to provide understanding for patients seeking HRT after breast cancer and insight for doctors on how to move forward without robust evidence. Dani Binnington, host of the Menopause And Cancer podcast, and founder of the not-for-profit organisation Menopause And Cancer has spoken to hundreds of women who feel like they are in a void and have nowhere to turn to when discussing this difficult topic. Welcome to our HRT after breast cancer series.In this episode we discuss:Why limited data and the changing landscape of breast cancer treatment make it challenging to provide definitive answers about HRT after breast cancer.How could we move forward without robust data?The challenges doctors face in prescribing HRT after breast cancer. How the establishing of a registry could provide doctors with confidence in prescribing HRT and contribute to the global sum of knowledge on the topic.Understanding and quantifying risk is crucial in the HRT conversation, and patient decision aids can help visualise the potential benefits and risks.Empowering patients with information and involving them in shared decision-making can help them make informed choices about their treatment options.Advancements in breast cancer treatment, such as selective oestrogen receptor degraders, offer hope for future options with fewer side effects.Episode Highlights:00:00 Intro.06:22 Empower patients to understand and manage treatments.13:36 Risk is a complex and multifaceted issue.19:20 Understanding benefits and risks, patient-doctor relationship.24:37 Health professionals collaborate for consensus on best practices.31:59 New drugs to manage hot flushes effectively.Connect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancer Join our Facebook group: www.facebook.com/groups/menopauseandcancerchathubThe walking challenge I mention is here for you: https://move-with-menopause-and-cancer.raiselysite.com/

This has been an exciting year with much more attention being paid to midlife women's hormonal health. Finally perimenopause/menopause is getting a voice, and the use of MHT (menopausal hormone therapy) is becoming widely accepted. Once we have decided to take menopausal hormone therapy, there are multiple options of products and routes of administration. Today I'll be discussing the different options for bioidentical menopausal hormone therapy, and the pros and cons of each. It's also important to understand why the doses are vastly different for the various different products, and why it's important to have your blood drawn to make sure that you are reaching optimal levels, because absorption is highly variable between patients. In the end, reaching the appropriate blood levels is much more important than the route of administration, which is really just a matter of personal choice and lifestyle. While the vital hormone testosterone continues to be controversial, in my practice we consider "optimal" for female testosterone to be in the upper range of what is physiologic for women (restoring levels to the high end of what they were when we were younger). Multiple studies have shown that these levels safely provide benefits for sexual wellness as well as muscle and bone conservation, sleep and mood. We recognize that long-term very high levels of testosterone put patients at risk of not only nuisance symptoms, but also irreversible masculinizing effects, which is why we never dose at that level, and why we have developed a novel dosing protocol which has proven to be safe and effective. Unfortunately, the practice of "Supra-physiologic dosing" continues elsewhere in the community, and is at the root of many people's misunderstanding about the safety of testosterone . We set ourselves apart from others who put their patients at risk with levels that are too high, and we pay the utmost attention to making sure we keep hormone levels optimal, without elevating risk.

The first episode of the HRT after breast cancer series features oncologist Dr. Leila Agrawal, who discusses the evidence, studies, and trials regarding HRT for breast cancer patients.Dr. Laila Agrawal is a medical oncologist and haematologist specialising in treating breast cancer patients. She is involved in research and clinical trials and she strives to get to know every patient and learn what is important in their lives, from their families to their goals, and how that plays into important decisions about their health.This mini-series explores hormone replacement therapy (HRT) after breast cancer, a controversial and emotive subject. The conversation focuses on the further understanding of risks and benefits of HRT (hormone replacement therapy) or also MHT (menopause hormone therapy), the emotional impact on patients, and the different views among medical professionals. The goal is to provide understanding for patients seeking HRT after breast cancer and insight for doctors on how to move forward without robust evidence. Dani Binnington, host of the Menopause And Cancer podcast, and founder of the not-for-profit organisation Menopause And Cancer has spoken to hundreds of women who feel like they are in a void and have nowhere to turn to in discussing this difficult topic. Welcome to our HRT after breast cancer series.In this episode we discuss:The role of hormone-blocking medications such as tamoxifen and aromatase inhibitors for breast cancer survivors.Dr. Agrawal discusses many studies on HRT after breast cancer, including the The Habits study which showed an increased risk of recurrence in the HRT group, leading to the trial being stopped early.She goes on to explain The Stockholm study which did not show an increased risk of recurrence.Dr. Agrawal explains other studies, including observational studies that looked at the use of hormone replacement therapy after breast cancer and explains the outcome of meta-analysis for different types of breast cancers. We discuss what these study results mean for different types of cancers, such as triple-negative breast cancer. Dr. Agrawal discusses the difference between absolute risk and relative risk is and why this is important when interpreting data.Additional research is needed to determine the safety and efficacy of HRT in breast cancer survivors.Episode Highlights: 00:00 Intro.04:19 Understanding patient perspectives and ethical medical decisions.08:10 Different types of breast cancer treatment options.09:52 Aromatase inhibitors used to treat breast cancer.17:01 Breast cancer trial halted due to risk.25:05 Stockholm Study.37:14 Interpreting risk reduction impact of treatments accurately.48:04 Data on tamoxifen and HRT remains inconclusive.53:25 Understanding and quantifying medical risks for patients.Connect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancerJoin our Facebook group: www.facebook.com/groups/menopauseandcancerchathub

We are joined by hypnotist, speaker, and researcher Jesse Beltran, C.Mht. He will provide us with the Gnosis to repel dark suggestibility, non-consensual experimentation, and other forms of techno-fascist brainwashing. From Havana Syndrome to covert technologies, get ready for that Ubik spray against the Archons and their Karens and Katamites in the Establishment. He'll also share his extraterrestrial encounters, views on consciousness, and participation in the dynamic Mind Nexus Live Event. More on Jesse and the Mind Nexus Live Event: http://www.cosmicclarityconnections.org/index.html  The Gnostic Tarot: https://www.makeplayingcards.com/sell/synkrasisHomepage: https://thegodabovegod.com/ Patreon: https://www.patreon.com/aeonbyteAB Prime: https://thegodabovegod.com/members/subscription-levels/ Virtual Alexandria Academy: https://thegodabovegod.com/virtual-alexandria-academy/Voice Over services: https://thegodabovegod.com/voice-talent/ Astro Gnosis (Meet the Archons): https://thegodabovegod.com/meet-archon-replay/Support this podcast at — https://redcircle.com/aeon-byte-gnostic-radio/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Send us a Text Message.Amanda Thebe discusses menopause advocacy, hormone therapy, and cortisol management, emphasizing the importance of workplace support and the benefits of strength training for women's health.00:00 Introduction to Amanda Thebe and her expertise in menopause advocacy and education06:40 Advocacy for Menopause Awareness and Education      13:20 Menopause advocacy in the workplace and its impact on mental health      20:00 Empowering women to speak up about menopause and its symptoms26:37 Understanding the difference between regulated and unregulated hormone therapy (MHT, HRT, BHRT definitions)      33:13 Discussion on the challenges of hormone therapy and the importance of finding the right healthcare practitioner39:52 The positive impact of stress on telomere length and longevity during menopause      46:35 The importance of strength training and muscle building in menopauseYou can find Amanda on her website: www.amandathebe.com Book - Menopocalypse: https://amzn.to/3YBfZcEThe Move Daily Membership is a paid monthly subscription for women, which gives you access to a huge amount of resources to help support you in reaching your health goals. Whether you're looking to lose fat, gain lean muscle, focus on your nutrition, give time to wellness or simply wish to dial in your overall health, we can support you in achieving your objectives. Join today!Support the Show.Thanks for moving daily with us in your fitness, wellness and nutrition! Be sure to follow us here:YouTube: https://www.youtube.com/@TracySteenMoveDailyInstagram: https://www.instagram.com/movedailyfitness/Facebook: https://www.facebook.com/tracy.steen1TikTok: https://www.tiktok.com/@tracysteenSubscribe to my podcast! https://www.buzzsprout.com/2375873/support

Hormone Replacement Therapy, or what's now being referred to more often as MHT, is rising in popularity. But who should take it? Which hormones is it replacing? Who is eligible? How does it help? So many good questions! Listener Amy had another good question: “Hi, Megan, I had a hysterectomy about five years ago. I'm being told that some women take progesterone, and I'm wondering if that's a good idea. And why do they take progesterone and not estrogen? Thank you so much.” While I'm no doctor, I can help shed some light on this popular, albeit confusing, topic. In this quick episode, I give you a brief history of HRT and how many of the risks associated with it have been debunked. Then we'll do a broad overview of estrogen vs. progesterone, and why you might take one or the other or both.

The conversation around hormone therapy for menopausal symptoms is pretty clear. Hormone therapy is the gold standard for treating hot flashes and night sweats and can help with many other common symptoms that come with the menopause transition. It's very effective and broadly safe. But recently, the conversation has evolved past symptom management and into preventative health with many experts suggesting that hormone therapy may play a larger role in extending a woman's healthspan, if not lifespan. That maybe we should all start taking hormones to protect our hearts and cognitive health. And there's promising research in those areas. Yet none of the medical associations recommend hormones for those purposes. Why? That's what we dig into this week with Professor Susan Davis, AO, who is a pioneer and leading expert in women's health as a clinical endocrinologist, researcher, and educator. She reflects on her decades of research on various forms of hormone therapy and shares what we know–and still don't know–today regarding traditional hormone therapy as well as testosterone therapy for women's health post menopause.Professor Susan R Davis AO, MBBS, FRACP, PhD, FAHMS is a clinician researcher with expertise in the role of sex hormones in women across the lifespan. She is Head of the Monash University Women's Health Research Program and holds a Level 3 NHMRC Investigator Grant. Susan is a Consultant Endocrinologist and Head of the Women's Endocrine Clinic, Alfred Hospital Melbourne and a consultant at Cabrini Medical Centre. She is a Fellow and Council Member of the Australian Academy of Health and Medical Sciences. She is a past President of the Australasian Menopause Society and the International Menopause Society. She has over 435 peer-reviewed publications and has received numerous national and international prestigious research awards. Susan was appointed an Officer of the Order of Australia for distinguished service to medicine, to women's health as a clinical endocrinologist and researcher, and to medical education. You can learn more about her and her work at Monash University.Resources2023 Practitioner's Toolkit for Managing Menopause hereMenopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery hereUse of MHT in women with cardiovascular disease: a systematic review and meta-analysis hereStudying Studies: Part I – relative risk vs. absolute risk by Peter Attia, MD, hereSubscribe to the Feisty 40+ newsletter: https://feistymedia.ac-page.com/feisty-40-sign-up-page Feisty Menopause Performance Retreat: Join us from November 21st-23rd, 2024 https://www.feistymenopause.com/retreat Follow Us on Instagram:Feisty Menopause: @feistymenopause Feisty Media: @feisty_media Selene: @fitchick3 Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099 Join Level Up - Our Community for Active Women Navigating the Menopause Transition:Join: https://www.feistymenopause.com/monthly-membership-1 Leave your questions for Selene:https://www.speakpipe.com/hitplay Get the Free Feisty Women's Guide to Lifting Heavy...

Should I take HRT? How do I know if it's menopause? What about testosterone? I'm worried about breast cancer. These are common questions that we get asked daily. Dr Lucy discusses this and more with menopause expert Dr Ceri Cashell. They discuss all the hot topics in relation to HRT or MHT for women going through menopause and perimenopause.  Downloadable checklisthttps://www.rlmedicine,com/checklist Previous episode 206 https://www.rlmedicine.com/what-is-the-difference-between-perimenopause-and-menopause Dr Ceri Cashell https://www.instagram.com/drcericashell/ https://www.healthyhormones.au/ Book recommendation Estrogen Matters by Avrum Bluming  Episode, show notes & transcript https://www.rlmedicine.com/menopause-perimenopause-and-hrtSee omnystudio.com/listener for privacy information.

What's new with menopausal hormone therapy (MHT)? Karolyn talks with integrative women's health expert Tori Hudson, ND, about the efficacy and safety of hormone therapy for the treatment of menopausal symptoms. They also discuss new hormone-free drugs that are now available, as well as natural measures to manage symptoms. Dr. Hudson is a pioneering women's health expert and an accomplished author, professor, and clinician. About the Expert Tori Hudson, ND, graduated from the National University of Naturopathic Medicine (NUNM) in 1984 and has served the college in several capacities. She is currently a clinical professor at NUNM, Southwest College of Naturopathic Medicine, and Bastyr University. Hudson is the medical director of A Woman's Time in Portland, Oregon, and director of product research and education for VITANICA. She is the founder and codirector of Naturopathic Education and Research Consortium (NERC), a nonprofit organization for accredited naturopathic residencies. Hudson is a faculty member of the Fellowship in Integrative Health & Medicine, Academy of Integrative Health & Medicine. Dr. Hudson is a nationally recognized author and her latest book is The Menopause Companion (2023).

This episode is quite the departure for the show and was born out of some Instagram stories around perimenopause, when I realized- hey, we all seem pretty uninformed! And more scary - way too many people are tuning into their fave influencers for peri content, which is becoming increasingly monetized. While I personally got my puberty education from the legend that is Judy Blume and a few school health classes, nothing like this quite exists for perimenopause. While we're starting to get more comfortable with the topic from a cultural standpoint, there's still so much confusion and disinformation on the internet. And with influencers recently jumping on the bandwagon, it's more difficult than ever to separate the snake oil from the science.Joining me today is Dr. Carley Akehurst, ND, founder and practitioner at Clementine Natural Health in Vancouver. With a keen interest in women's health and evidence, science based care, I ask her all your burning questions from Instagram. From when perimenopause can start and what it commonly and not so commonly looks like, to Menopause Hormone Therapies (HRT/MHT), and how to talk to your doctor in an informed way. Consider this your crash course; the things you wish you knew to gear up for transitioning into perimenopause.  Please be responsible and use this information as a tool in your arsenal to be better informed. Medicine is not one size fits all, and you should speak to your own practitioner for specific health concerns. I learned so much, and hope you do too.Support the pod! If you like the pod, please consider supporting by sharing with friends and subscribing wherever you get your podcasts. We also love reading reviews, so please rate us 5 stars and write a review on Apple or Spotify. It goes a long way and is much appreciated! For a more dynamic experience, follow us on Instagram @haveyouheardpodcast. So many of our episodes, including this one, are shaped through discussions with listeners.Helpful references and links:Follow Dr. Carley Akehurst and her clinic, Clementine Natural Health on InstagramVisit Clementine Natural HealthFind a Certified Menopause practitioner near you through the Menopause SocietyThe Centre for Menstrual Cycle and Ovulation Research 

In our previous Menopause episode, we dove down into the depths of menopausal symptoms, touching on hot flashes, vaginal dryness, mood swings, etc. Luckily, in today's episode we march straight back up, discussing various forms of menopausal management that can support women through this transition and help dampen the adverse side effect of menopause.Dr. Polous explains menopausal hormone therapy, or MHT, which is the process of supplementing women with hormones that are lost during the menopausal transition.There are a range of MH therapies that can be used to lessen the effects of hot flashes, night sweats, insomnia, mood swings, etc.MHT is even often prescribed for prevention of coronary heart disease and osteoporosis.Dr. Polous discusses who would be a good candidate for MHT and how to go about having this discussion with your doctor.Show-Notes for this episode and others: https://www.notsoprivateparts.net/show-notesInstagram: https://www.instagram.com/notsoprivatepartspod/

While the safety and benefits of menopausal hormone therapy (MHT) are becoming widely accepted, hot debate continues around dosing, delivery methods and how to monitor levels. Advisory boards including the American College of Ob/Gyn and the Menopause Society support the use of (MHT), but much confusion continues regarding ideal blood levels, whether to check blood levels at all, and optimal route of delivery. The dosing of both estradiol and testosterone varies 5-10 fold between methods such as patches, gels, sublingual methods or pellets. Both doctors and patients need to understand the dose that they are prescribing to make an educated decision. Today I will help to shed light on the differences between these options, and why my strong opinion is that blood levels are critical to ensure that levels are not too high or low for your optimal health.

Welcome back to Midlife Revival Podcast! Dr. Taniqua Miller, board-certified OBGYN and perimenopause coach, shares invaluable insights on menopausal hormone therapy (MHT) in this episode. She breaks down five key goals to consider when exploring MHT, emphasizing the importance of understanding its purpose, managing expectations, and addressing psychosocial aspects of midlife. Dr. Miller provides clarity on when laboratory testing is necessary, highlights the evolving nature of hormone needs, and stresses the importance of seeking specialized care when needed. Join her as she demystifies menopausal hormone therapy, empowering women to embrace midlife with confidence and vitality.Ready to claim your midlife revival? Book your sales call with Dr. Taniqua Miller, transformational perimenopause coach. In her 1:1 coaching, she helps perimenopausal women overcome their bothersome physical symptoms of menopause while working to create a midlife pivot that will bring back pleasure and joy in their lives. Schedule your sales call today!https://calendly.com/taniquamd/sales-call-for-boundless-midlifeFollow Dr Taniqua Miller on Instagram @taniquamillermd and Revival Telemedicine @joinrevival.*** Interested in booking your own menopausal consultation? If you are in the states of GA or TX, you may do so at taniquamd.com/patients. I look forward to serving you!

"What I've found, after 25 years of seeing clients is that, we're adolescents living in grown-up clothes"Today I have a very special guest on the show. She's Michelle Chalfant, MC, LPC, CHC, MHt, a licensed therapist, master life coach, author, podcaster and motivationalspeaker. We had a deep and profound talk about relationships, its communications' issues, how to work with your inner child and figuring out how to live a healthy grown-up life.Her work has helped people all over the globe get unstuck, find their true self,grow their self-worth and improve their relationships, creating a life of true freedom and empowerment!Blending simple psychology and grounded spirituality, her work gives people the practical tools and techniques they can use to access their personal power and  transform their lives.With more than 25 years of experience as a therapist and coach and extensive training in diverse self-healing methods, Michelle's mission is to bring healing to this world through online courses and her coaching certification program, where she trains others in her signature coaching model that is designed to bring fast transformation through experiential work.To learn more about Michelle and her incredible work, visit theadultchair.com and listen to her podcast  The Adult Chair®You can get your Free Inner Child Resource hereAnd the Free Guide: 5 Healthy Relationship “Myths” Keeping You Disconnected From Your Partner here  TODAY'S HIGHLIGHTS (00:00) Intro (01:30) In today's episode… (03:05) The High Frequency Mastermind starts this month. Discover your zone of genius (08:22) A little bit of Michelle's story (10:36) The 3 phases of The Adult Chair model (13:37) The most important lens to look at relationship through (17:11) Communication: why is it a common problem in relationships? (21:56) Traditional talk therapy, IFS, and Parts Work (27:06) Working with your inner child (39:23) Relationship work vs Ending your relationship. Cleaning your personal slate (43:17) Navigating through projections. The co-dependency realization (53:09) How do I not pass my past traumas to my kids? (58:36) Freebies **WAYS TO ENTER MY WORLD**  When you leave a review of the podcast, send us a screenshot and we'll send you a $250 credit, you can apply to anything else in my world.  YOU are the only one who knows the best way for you to :  10x your incomeStructure your businessDecide which growth strategies to implementAND you can access your ability to channel all of it through your BREATH. Sign up for The High Frequency Mastermind to receive individualized guidance on how to apply it to grow your business. CONTACT ALYSEJoin my Facebook group: Financial Freedom for Spiritual EntrepreneursFollow and DM me on Instagram @alyse_breathesVisit https://www.alysebreathes.com/Or contact me at info@alysebreathes.com

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HERE---Episode Overview: How can we positively impact mental healthcare through technological innovation? According to our next guest, Ernie Wallerstein, CEO of Mental Health Technologies, it starts by enabling quantifiable improvements in patients' journeys to wellness.Driven by a passion to address the growing challenges of providing mental health and substance abuse services, Ernie and his team built an innovative SaaS platform that seamlessly integrates validated psychometric testing into healthcare providers' existing workflows.While together, Ernie shares how MHT's technology empowers medical professionals to -screen patients, objectively collect mental health data, and enhance billing practices. Ernie also reveals his vision for horizontally integrating the entire mental health process and leveraging data analytics to proactively identify negative treatment trends.Join us to learn how Ernie and the MHT team are streamlining mental health screening through technological innovation! Let's go! Episode Highlights:Integrating seamlessly into existing EHR/EMR systems to minimize workflow disruption for healthcare providersAchieving over $1 million in annual recurring revenue while bootstrapped, without VC or PE funding60% patient completion rate for MHT's assessments, demonstrating strong engagementPositioning MHT's data analytics capabilities to predict optimal assessments and identify negative treatment trendsAddressing a critical need by enabling better identification and care pathways for mental health/substance abuse About our Guest: Ernie Wallerstein is revolutionizing the mental health industry by enabling quantifiable and qualitative improvements in patients' journey to wellness. Through his innovative SaaS assessment platform, medical practitioners can seamlessly administer a range of validated psychometric tests, providing a comprehensive understanding of patients' mental health.Links Supporting This Episode:MHT Website: CLICK HEREErnie Wallerstein LinkedIn page: CLICK HEREErnie Wallerstein Twitter page: CLICK HERE Mike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

Today, we're delighted to have John Cray with us, a visionary working at the forefront of mental health technology. As you already know, our show champions the idea of minimizing tech use to reconnect with the tangible aspects of life, thereby enhancing our physical and mental well-being. Yet, we also recognize the importance of not missing out on the remarkable advancements technology offers. John brings a unique perspective to this conversation, having deeply considered the balance between tech utilization and health.   In this episode you will hear:  What it means to measure mental health.  Why it is good that celebrities and athletes are more open about their mental health. How SmarTest is changing the field of mental health for patients and providers.  Ways in which clinics and schools can utilize testing to help students.  The power in early detection of mental health struggles.    John Cray, the Chief Technology Officer at Mental Health Technologies (MHT), is a key figure in revolutionizing mental health care through technology. At MHT, he has been instrumental in developing a cloud-based platform that primary care physicians and mental health professionals use for screening and testing mental health disorders, including depression and substance abuse.    This platform, known for its innovative approach, helps healthcare providers identify areas where patients are struggling and efficiently refer them to appropriate behavioral healthcare professionals.   His latest tool, SmarTest, is a groundbreaking addition to MHT's technological suite. This innovative tool leverages intelligence and historical data to precisely determine the most appropriate times and methods for testing patients for various mental health conditions. Tailoring its approach based on individual patient information like age and gender, SmarTest offers a personalized and efficient solution for mental health screening.      Connect with John Cray: Website: https://www.mhtech.com/  LinkedIn: https://www.linkedin.com/in/john-cray-7182271/  Twitter: https://twitter.com/mhtsocial      Connect with R Blank and Stephanie Warner:  For more Healthier Tech Podcast episodes, and to download our Healthier Tech Quick Start Guide, visit https://HealthierTech.co and follow https://instagram.com/healthiertech Additional Links: Shield Your Body website: https://ShieldYourBody.com Shield Your Body Youtube Channel: https://youtube.com/shieldyourbody Host R Blank on LinkedIn: https://www.linkedin.com/in/rblank9/ Shield Your Body on Instagram: https://instagram.com/shieldyourbody  

Dr. Christina Prevett // #ICEPelvic // www.ptonice.com  In today's episode of the PT on ICE Daily Show, #ICEPelvic division leader Christina Prevett discusses the role of estrogen in the body, the important role estrogen (or lack thereof) may play in rehab outcomes, assessing menopause in the clinic, and hormone replacement therapy. Take a listen to learn how to better serve this population of patients & athletes. If you're looking to learn more about our live pregnancy and postpartum physical therapy courses or our online physical therapy courses, check our entire list of continuing education courses for physical therapy including our physical therapy certifications by checking out our website. Don't forget about all of our FREE eBooks, prebuilt workshops, free CEUs, and other physical therapy continuing education on our Resources tab. Are you looking for more information on how to keep lifting weights while pregnant? Check out the ICE Pelvic bi-weekly newsletter! EPISODE TRANSCRIPTION INTRODUCTION Hey everyone, this is Alan. Chief Operating Officer here at ICE. Before we get started with today's episode, I want to talk to you about VersaLifts. Today's episode is brought to you by VersaLifts. Best known for their heel lift shoe inserts, VersaLifts has been a leading innovator in bringing simple but highly effective rehab tools to the market. If you have clients with stiff ankles, Achilles tendinopathy, or basic skeletal structure limitations keeping them from squatting with proper form and good depth, a little heel lift can make a huge difference. VersaLifts heel lifts are available in three different sizes and all of them add an additional half inch of drop to any training shoe, helping athletes squat deeper with better form. Visit www.vlifts.com/icephysio or click the link in today's show notes to get your VersaLifts today. CHRISTINA PREVETT Hello, everybody, and welcome to the PT on Ice Daily Show. My name is Christina Prevett. I am one of the lead faculty within our pelvic division. And y'all, the pelvic division has been just really busy over the last couple of weeks, couple of months, heck, the entire year. But if you did not see, we actually just sold out our first online cohort for 2024. And so that is sold out. So our next cohort for our online level one is March 5th. Our brand new inaugural cohort for level two, if you've taken level one, is April 30th. And in 2024, I am going to be in Raleigh, North Carolina with Rachel Moore, January 13th, 14th. And Alexis is going to be teaching in Hendersonville, 27th, 28th of January. And then we're heading over to Bellingham, Washington, February 3rd and 4th. Those are the first three courses of 2024 if you guys are interested in coming to our live course and doing some of our skills check for cert. ESTROGEN & REHAB Okay, so I kind of want to talk about estrogen and specifically estrogen in later life and lack of estrogen and how it influences rehab. So this has been something that I've been really kind of geeking out about over the last little while around, you know, not just as pelvic therapists, but as anybody working with a person going through menopause, if you are working with anybody over the age of 50, a female over the age of 50, you are interacting with a person who is going through estrogen depletion in their body. And As I've learned more about the influence of estrogen on our bodies, the more I am recognizing even outside or maybe even especially outside of the context of pelvic health when I'm seeing people who are postmenopausal, but in my orthopedic rehab, how much it is influencing our outcomes. and just a person, a person who is a female in an aging body, what the lack of estrogen may do for the way that we experience aging. And then I kind of want to cap this podcast off talking a bit about some of the myths and misconceptions around estrogen replacement therapy. or menopause replacement therapy. And we'll talk a little bit about the change in the labeling of these types of treatments and where some of the thoughts around risk for things like sex-related cancers has come up. So to start this off, I want to start with a story. So I was working with a woman who was coming in. She was in her early 60s and dealing with shoulder pain. She had a history about 10 years ago of frozen shoulder. So when it comes to adhesive capsulitis, we know that being a female and being kind of in middle age is a risk factor. And I never really thought about that risk factor being linked to estrogen status or like the beginning of perimenopause. Still wasn't really thinking about it. But she said, you know, that was a really long journey when her shoulder froze. And but it got better, got better over time. She realized that she was going through hormone replacement therapy or she was going through menopause. She got put on hormone replacement therapy. She was on it for 10 years. And then her doctor on a follow up where she was trying to get a renewal said, actually, you've been on it for too long. I'm going to take you off of it, which that That's a whole other ethical scenario, especially because we should be weaning off estrogen replacement therapies, not just going cold turkey. But however, took her off and within a couple of months of that weaning process, her other shoulder started to freeze. I've obviously been in the weeds of this research right now around the influence of estrogen on our body, but I was thinking about and reflecting on how many women I have worked with over my career. THE INFLUENCE OF ESTROGEN ON OUTCOMES I've been a PT for 10 years, so very still early on in my career, but how many have I not recognized the influence of a person's estrogen status on our outcomes? And so when we think about estrogen, we think about fertility, rightfully so. We think about pelvic floor physical therapists kind of specializing in the fertility space, granted, but estrogen, when we have a depletion in estrogen as women go through menopause, it affects every part of our body where there is an estrogen receptor. And I don't think that many orthopedic therapists or people who kind of aren't niching into this space, myself included until I got into this arena, recognize just how widespread that is. And in pelvic health, we've done an incredible job of advocating for individuals in the perinatal space. We still have, of course, ways to go. However, you know, there's this rise of individuals going through menopause who are starting to advocate that we need that same type of education. And too frequently now that I've been asking are my patients saying to me, oh, well, my doctor said it was just part of aging and I shouldn't be on hormone replacement for this long or like have just been dismissed about their symptoms and have not linked some of these other body systems and the experiences that they're having in these other body systems with their estrogen depletion. I have a client seeing me for ankle pain and she's kind of in that postmenopausal window and she said, I am trying to learn a new body that I do not understand. And I think that was such a profound statement because so many individuals are feeling this way and we have a huge role to play in rehab. And I'm not talking pelvic, I'm talking generally. THE ROLE OF ESTROGEN IN THE BODY And so when we think about estrogen, estrogen has receptors in our brain. It has receptors in our joints and muscles. It has receptors in our heart, and it influences our bone, right? Bone is probably the easiest one. We know that individuals who are postmenopausal are at increased risk for osteoporosis osteopenia, that there is an accelerated rate of decline in bone mineral density loss with estrogen as rates of, estrogen helps rates of bone build up. And with estrogen depletion, we see a switch in the slope of the line where bone breakdown exceeds rate of bone growth. And so rates of osteoporosis go up postmenopausally. We also see that individuals who are in an estrogen depleted state have higher rates of joint pain. So kind of an umbrella term of joint arthralgia. and we see links to risk factors around things like adhesive capsulitis in individuals going through perimenopause, but very little research has actually looked at individuals' experiences of musculoskeletal pain in the postmenopausal window. So we could have individuals who are not responding as quickly to rehab, even though we're throwing everything at them that is evidence-based and evidence-informed, because they are going through menopause and it's the influence of their hormones is changing the way that their body is responding to some of our rehab interventions and we don't know about it. Our body also has estrogen receptors in the heart. And so we see that men tend to have a higher rate of cardiovascular disease and heart disease than women, but that change in rate between men and women starts to change in that postmenopausal window. So rates of heart disease start to go up postmenopausally because of the protective effect of estrogen on the heart. What we also see from a metabolism perspective is that there is a change to the way that fat is laid down when individuals are postmenopausal. So where we have the protective subcutaneous fat that tends to be something that is kind of a net, potentially neutral way of laying down fat, the more dangerous fat is visceral fat lay down, and that tends to accelerate in a postmenopausal female because of estrogen deficiency. which then increases risk for a whole bunch of different metabolic diseases, including, you know, heart disease, stroke, Alzheimer's disease, like all these diabetes, all of these things that we know are linked to pro-inflammatory cascades. It accelerates for individuals as they go through menopause. And then finally, from a cognition perspective, we have systematic review evidence that Individuals who go through premature ovarian insufficiency. So individuals who go into menopause before the age of 40 are at an increased risk for cognitive decline. So rates of Alzheimer's are higher in individuals who go through early menopause. And we see that there may be a protective effect, preventative effect of the development of cognitive decline for these individuals who are going through menopause early if they are on hormonal contraception. Which gives a very strong argument for the link between estrogen status and cognition. And when we think about symptoms of menopause, we kind of put them into different buckets. We talk about, you know, vasomotor symptoms, which are night sweats, issues with sleep, sleep disturbances are very high around the postmenopausal or menopausal transition, and hot flashes. Right? And there's kind of like this immediate withdrawal effect of estrogen. Like you could almost think about it as like a drug withdrawal. Like when we get withdrawn from estrogen, those vasomotor symptoms kick up. And then eventually our body gets used to being in that state of estrogen deficiency and those withdrawal symptoms kind of go away. But genitourinary syndrome of menopause is really focused on the aging of the pelvis and its influences. And so when we're in pelvic health and we're talking about estrogen deficiency, we see, you know, adhesions in the labia minora to the labia majora. We see an increase in friability of tissues. We see an increase or a changes to the pH of the vaginal microbiome. And so these all have influences, but the genital urinary syndrome very much focuses on the pelvis. ASKING ABOUT MENOPAUSE And so if you are not in pelvic health, you may not be really considering it a reason to be asking about symptoms of menopause and when you went in through menopause. But if you are an individual who is working with anybody who is a female over the age of 50, you should be asking, are you in menopause? Have you gone through menopause? When did you go through menopause? And menopause is diagnosed as the 12 month mark of not having a period. So when you have not had a period for 12 months consecutively, that is considering being in menopause. Average age is 50 to 51 in the United States. asking around changes in symptoms around the menopausal transition. Did you notice a change to your mood? Did you see a change to your sleep? Did you see a change to your cognition? Did you see a change to all these other things? Because we know that if you're depressed and not sleeping and your joint pain is up, we're probably gonna have a lot of conversations that we need to have around recovery. It's gonna influence the way that our treatment is going to go. And then we can be an advocate for ways to manage. Too often, and there is nothing that makes me more mad. Like when I see individuals who have gone to their doctor and they say, I am suffering with vasomotor symptoms. I am suffering with all of these things. And they say, I have no libido. And they say, well, you are going through menopause. And that's kind of the way it is. Men will get Cialis or other types of hormone replacement for their sexual dysfunctions very readily. And it is met with hesitation when we are talking about female reproductive aging. And I was just at a course where it has some individuals who are part of the military and the military nurse practitioners were there, which is really cool. But they said, you know, we are so willing to prescribe Cialis but we are very hesitant as a division to give hormone replacement therapy. HORMONE REPLACEMENT THERAPY And so the next part of this conversation, one, estrogen affects everything. It's absolutely gonna influence our pelvic floor. It's absolutely gonna influence our pelvic health. But then the next thing that people are asking is around estrogen replacement therapy, sex hormone replacement therapy, and its safety and efficacy. So I wanna do a little bit of a history lesson here around where this risk is coming from. So there is a large longitudinal study called the Women's Health Initiative that has been collecting data on women for a very, very long time. And early, early on in about 2001, a study was released from the Women's Health Initiative that said that there was a 25% increased risk of sex-related cancers for individuals who are on hormone therapy than individuals who are not. This was, potent, like kind of true, but it missed the forest for the trees. And so when we kind of zoom out and we look at relative risk of sex-related cancers, that, well, that translated into, instead of it being three in 1,000, and these are not perfect numbers, I don't remember off the top of my head, it changed to a four in 1,000 rate or incidence of sex-related cancers. When if you think about it like that, that is not the biggest difference. However, that one study came out and it changed everything. It was largely disseminated, many media outlets put it up, and it made everybody very, very fearful of prescribing hormones. So there's a couple things nuanced to this. When we are taking any type of medication and our sex hormones are not anything different, there is always going to be potential risks. Those have to be balanced by the benefits. We see, for example, that individuals who are on replacement therapy have a lower risk of Alzheimer's, dementia, especially if individuals are going through a menopause early. We see sexual health, sexual, satisfaction increases on hormone replacement therapy. We see an increase or rather a decrease in rates of urinary tract infections. And if you are working in the geriatric space, move this into Wednesday. It makes a huge difference. A urinary tract infection can change a person's life. A person can die of a UTI because it can end up, they get in hospital, UTI becomes sepsis, sepsis becomes a full blown, you know, it's now a full blown infection and individuals don't get out of hospital or they see a consistent change in function. All of these benefits for many are going to outweigh that slight increase in risk. Now, we have evidence since then that that risk percentage may have actually been when we replicate a study, which is super important before we're making very broad sweeping statements. There is a range of that relative risk and it actually might be lower. And because of that, we now have good evidence for individuals who are going through chemo to be able to have, because it can irradiate and bring you into a low estrogen state, where they may use topical estrogens. We have more evidence for individuals who are on estrogen receptor blockers, like tamoxifen, to, again, have topical estrogens. Because, obviously, we're not gonna wanna ingest estrogen when we're trying to block it so that cancer doesn't regrow, but to put it on the external genitalia, that would allow us to remove some of those pelvic-related symptoms for individuals being in low estrogen as a consequence of cancer treatment. And this evidence is continuing to grow. NO EVIDENCE FOR AN OPTIMAL HORMONE REPLACEMENT WINDOW The other question, when I go back to my patient that I talked about, is that he said, well, you've been on it for enough, this physician, and I'm gonna take you off. We actually, again, don't really have any evidence around where that window is. Like how long you can be on it before the risks start to outweigh the benefits. And because we don't know, individuals are just creating a risk tolerance zone for themselves and then unilaterally kind of applying it in their practice. And so we still have so much work to do in this space. We are starting to see a change in our language around hormone replacement therapy, and it's being changed to MHT, menopausal hormone therapy. And it is actually encompassing a variety of different treatments. It is not just a systemic pill that you can take that is a natural replacement, there is those. There are progesterone replacements. There are estrogen and progesterone combos. There is evidence for testosterone replacement and testosterone replacement helping individuals with hyposexual disorders. And then there are topical estrogen therapies where individuals who are experiencing recurrent UTI, individuals with issues with labial adhesions, individuals with clitoral adhesions, all these different things can see a huge benefit to this type of hormone replacement. And so, The role that we have to play here, if you were a pelvic clinician listening to this, we have a ton of advocacy to work on. Staying up to date with the evidence, referring back for potential counseling on hormone replacement, and continuing to have those conversations with our physicians is gonna be super important. If you are a person who's an orthopedic specialist, you need to be asking about estrogen status. Have you lost your menstrual cycle? That puts you in low estrogen. Have you recently had a baby? If you're a postpartum and you're dealing with a wrist injury, that low estrogen is gonna impact your ligaments. It's going to make it so that you may be more likely to have things like mom wrist decorvains tendosynovitis. And then if you're working with individuals who are older, then again, we're gonna be asking about when you went through that menopausal transition and how you're feeling. A lot of people feel like, oh, well, I'm going okay through my menopause right now. I don't really need it. The thing is estrogen deficiency is accumulative. So it is also a discussion around the preventative aspect of continuing to have individuals on hormone replacement. I don't know the answer to this, but it is a continual conversation. It is one that is happening in lots of spheres and one where there is a role for rehab. And this has been such an important part of the development of our research base in pelvic and a huge portion of the proportion of individuals that we are seeing in our practice that we have put it into our level one. So we have an entire week on the influence of menopause on the female body and an entire module on the way that we would work towards treating individuals and advocating for individuals who are going through menopause, who are subsequently feeling issues with pelvic health. So if you are interested, get into our March cohort. I could rant about this all day. I'm already 20 minutes in. I'm gonna get off here, but it's important. And it is not just important to our pelvic health clinicians. It is important for everybody who is working with a female body over the age of 50. And we're not even going to go into the perimenopause part because perimenopause could be 10 years before. So if you're working with anyone over the age of 40, this is relevant and it influences our rehab outcomes. All right. I hope you all have a wonderful week. Merry Christmas. If you are off, happy holidays. Whatever denomination you are, please hopefully have some time to spend with loved ones. And I hope that you get some of the rest and relaxation that is just something that you are looking for. I have two little ones, four and two, and the magic of Christmas and the holiday season is so alive and well in our house, and it is such a beautiful thing. So I hope you all get that. You are so welcome for me talking about this. I promise you, I will be diving more into this onto my personal Instagram, and it's definitely gonna come onto ICE because I think it's really important, and I think it's a huge miss that we have. So thank you for listening, and I am so excited to continue these conversations. Merry Christmas, happy holidays, and hopefully you get all of that rest and relaxation for the end of 2023. OUTRO Hey, thanks for tuning in to the PT on Ice daily show. If you enjoyed this content, head on over to iTunes and leave us a review, and be sure to check us out on Facebook and Instagram at the Institute of Clinical Excellence. If you're interested in getting plugged into more ice content on a weekly basis while earning CEUs from home, check out our virtual ice online mentorship program at ptonice.com. While you're there, sign up for our Hump Day Hustling newsletter for a free email every Wednesday morning with our top five research articles and social media posts that we think are worth reading. Head over to ptonice.com and scroll to the bottom of the page to sign up.

Menopause is not a monolith. We all experience this stage of life differently and require unique care. So this week we sat down with Dr. Heather Hirsch, author of Unlock Your Menopause Type to talk about the six basic types she sees in her practice, including premature, sudden, full-throttle, mind-altering, seemingly never-ending, and silent and the care they require. We also dig into the controversial topics of hormone testing and menopausal hormone therapy for perimenopause. Heather's ultimate goal is to give all women the information they need to make fully educated decisions about their care. And we're happy to support that mission on the show this week.Dr. Heather Hirsch is board certified in internal medicine and completed advanced fellowship training in women's health at the Cleveland Clinic. Her clinical work and research centers on inequalities and unanswered questions in the field of gynecology and women's health, specifically in menopause and its role in chronic disease development. Heather was the founder of the Menopause and Midlife Clinic at Brigham and Women's Hospital in Boston Massachusetts. She is also a private telemedicine practitioner at Heather Hirsch MD, PLLC. You can learn more about her and her work at heatherhirschmd.comResources:The ABCs of MHT with Heather Hirsch, MDUnlock Your Menopause Type by Heather Hirsch, MD, MS, NCMP with Stacey Colino Follow Us on Instagram:Feisty Menopause: @feistymenopause Feisty Media: @feisty_media Selene: @fitchick3 Subscribe to the weekly Feisty Menopause blog: https://www.feistymenopause.com/feistyinbox Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099 Join Level Up - Our Community for Active Women Navigating the Menopause TransitionJoin: https://www.feistymenopause.com/monthly-membership-1 Leave your questions for Selene:https://www.speakpipe.com/hitplay Get the Free Feisty Women's Guide to Lifting Heavy Sh*t:https://www.feistymenopause.com/liftheavy Support our Partners:The Amino Co: Shop Feisty's Favorite 100% Science-Backed Amino Acid Supplements. Enter code HITPLAY at Aminoco.com/HITPLAY to Save 30% + receive a FREE gift for new purchasers! Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/ Cool-Jams: Use the code HITPLAY for 15% off all products at https://www.cool-jams.com/?utm_medium=podcast&utm_source=spotify&utm_campaign=hit-play-not-pause_20230802 Nutrisense: Go to nutrisense.io/hitplay and use the code HITPLAY30 for $30 off any subscription to the CGM program